A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.

MLA

Yu, Jing, et al. “A Nomogram to Predict the High-Risk RS in HR+/HER2-Breast Cancer Patients Older than 50 Years of Age.” Journal of Translational Medicine, vol. 19, no. 1, Feb. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12967-021-02743-3.

APA

Yu, J., Wu, J., Huang, O., He, J., Zhu, L., Chen, W., Li, Y., Chen, X., & Shen, K. (2021). A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age. Journal of Translational Medicine, 19(1), 1–10. https://doi.org/10.1186/s12967-021-02743-3

Chicago

Yu, Jing, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, and Kunwei Shen. 2021. “A Nomogram to Predict the High-Risk RS in HR+/HER2-Breast Cancer Patients Older than 50 Years of Age.” Journal of Translational Medicine 19 (1): 1–10. doi:10.1186/s12967-021-02743-3.